Cafepharma Today

June 4 2025 - Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Moderna will test new COVID shot against placebo, Robert F Kennedy Jr. says
Massachusetts’ life sciences job growth flattens after 10+ years of increases
CDC official overseeing COVID-19 vaccine recommendations resigns
Lilly inks deal worth up to $870M to develop long-acting GLP-1 obesity drugs
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Millennium starts Phase 3 trial for amyloidosis
Mass High Tech, MA
Saturday, October 20, 2012 - 11:46am
tags:
MLN9708, Millennium, amyloidosis
Savient Receives Positive CHMP Opinion for Krystexxa Approval in the EU
Equities.com
Saturday, October 20, 2012 - 10:54am
tags:
Krystexxa, Savient, gout
Valeant (VRX) Buys its Way to the Top
Cabot Investing Newsletters
Saturday, October 20, 2012 - 10:52am
tags:
Valeant Pharmaceuticals
Alliance Pharma acquires Opus Group
HealthInvestor, UK
Saturday, October 20, 2012 - 10:50am
tags:
Alliance Pharma, Opus Group
Isis Trading Halts as FDA Reviews Key Drug's Risks
PharmPro
Saturday, October 20, 2012 - 10:49am
tags:
Isis Pharmaceuticals, Kynamro, hypercholesterolemia
Abbott Labs Shares Slide on Kidney Study
PharmPro
Saturday, October 20, 2012 - 10:46am
tags:
Abbott Laboratories, Bardoxolone, Reata Pharmaceuticals
3 Humongous Health-Care Stocks This Week
Motley Fool
Saturday, October 20, 2012 - 10:43am
tags:
Siemens, Aegerion, Given Imaging
Is Eli Lilly Narrowing in on the Billion Dollar Prize?
Wall Street Cheat Street
Saturday, October 20, 2012 - 10:40am
tags:
Eli Lilly, Alzheimer's disease, solanezumab
4 Reasons To Sell Merck Now And Buy It Back Later For Less
Seeking Alpha
Saturday, October 20, 2012 - 10:39am
tags:
Merck
2 BioPharma Stocks to Avoid, 1 to Buy
Motley Fool
Saturday, October 20, 2012 - 10:38am
tags:
Pfizer, Merck, JNJ
Aegerion CEO on Cholesterol Drug Lomitapide
Bloomberg
Saturday, October 20, 2012 - 10:37am
tags:
Aegerion, lomitapide, hypercholesterolemia
What Does This Rejection Mean for Obesity Drugmakers?
Motley Fool
Saturday, October 20, 2012 - 10:36am
tags:
Vivus, Qsymia, obesity, weight loss, Belviq, Arena Pharmaceuticals
3 Horrendous Health-Care Stocks This Week
Motley Fool
Saturday, October 20, 2012 - 10:33am
tags:
Isis Pharmaceuticals, Align Technology, MannKind
Celgene Corporation (CELG): Today's Featured Health Care Laggard
The Street
Saturday, October 20, 2012 - 10:32am
tags:
Celgene
1 Stem-Cell Spinout You Must Watch
Motley Fool
Saturday, October 20, 2012 - 10:32am
tags:
BioTime
Ziopharm slips on report that co withheld warning on trial data
Reuters
Saturday, October 20, 2012 - 10:31am
tags:
Ziopharm, soft tissue sarcomas, palifosfamide
Biogen slips as FDA extends review of MS drug
Yahoo/AP
Saturday, October 20, 2012 - 10:29am
tags:
Biogen, BG-12, MS, multiple sclerosis
An FDA Decision Is on the MAP
Motley Fool
Saturday, October 20, 2012 - 10:28am
tags:
Levadex, MAP Pharmaceuticals, migraines
CRL/AstraZeneca Join Forces
Yahoo/Zacks
Saturday, October 20, 2012 - 10:27am
tags:
Charles River Laboratories, AstraZeneca
Earnings Beat at Cubist Pharma
Yahoo/Zacks
Saturday, October 20, 2012 - 10:26am
tags:
Cubist Pharmaceuticals, earnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.